• LAST PRICE
    244.1200
  • TODAY'S CHANGE (%)
    Trending Down-0.0300 (-0.0123%)
  • Bid / Lots
    238.9900/ 1
  • Ask / Lots
    290.4600/ 1
  • Open / Previous Close
    242.5600 / 244.1500
  • Day Range
    Low 242.3000
    High 246.6100
  • 52 Week Range
    Low 148.0000
    High 277.3400
  • Volume
    114,676
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 244.15
TimeVolumePEN
09:32 ET3212242.56
09:35 ET124243.12
09:50 ET628243.62
09:51 ET1799243.7
09:53 ET1125245
09:55 ET194244.58
10:02 ET100245.74
10:04 ET876246.61
10:20 ET900244.915
10:22 ET400245.68
10:24 ET125244.905
10:29 ET100245.285
10:33 ET100244.86
10:38 ET500244.27
10:42 ET300244.43
10:45 ET1367244.42
10:47 ET1299244.61
10:51 ET129244.81
10:54 ET500244.025
10:56 ET1470244.67
10:58 ET226244.64
11:03 ET100243.965
11:05 ET100243.94
11:07 ET400244.12
11:09 ET200244.09
11:12 ET100243.9
11:14 ET200243.645
11:16 ET200243.74
11:21 ET300243.77
11:23 ET200244.07
11:25 ET200244.08
11:27 ET160244.137
11:34 ET221243.85
11:36 ET100243.665
11:38 ET1110243
11:39 ET236242.78
11:43 ET1147242.76
11:45 ET226242.53
11:48 ET1100242.65
11:50 ET200242.925
11:52 ET100242.87
11:59 ET400243.1
12:01 ET200243.25
12:03 ET564243.42
12:08 ET100243.525
12:14 ET494243.86
12:19 ET100243.965
12:21 ET200243.73
12:24 ET100244.05
12:28 ET200243.78
12:32 ET301244.1
12:37 ET100244.08
12:44 ET405244.49
12:46 ET321244.505
12:48 ET101244.68
12:50 ET227244.78
12:57 ET200244.29
01:00 ET39317244.12
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPEN
Penumbra Inc
9.4B
283.8x
+65.82%
United StatesMASI
Masimo Corp
9.2B
118.7x
-15.37%
United StatesRGEN
Repligen Corp
8.2B
-488.9x
+15.08%
United StatesBIO
Bio Rad Laboratories Inc
9.5B
-12.5x
---
United StatesGKOS
Glaukos Corp
7.9B
-48.5x
---
United StatesTFX
Teleflex Inc
8.9B
38.2x
+12.49%
As of 2024-11-29

Company Information

Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

Contact Information

Headquarters
One Penumbra PlaceALAMEDA, CA, United States 94502
Phone
510-748-3200
Fax
302-531-3150

Executives

Chairman of the Board, President, Chief Executive Officer
Adam Elsesser
Chief Financial Officer
Maggie Yuen
Executive Vice President, General Counsel, Secretary
Johanna Roberts
Chief Accounting Officer
Lambert Shiu
Director
Arani Bose

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$9.4B
Revenue (TTM)
$1.2B
Shares Outstanding
38.4M
Penumbra Inc does not pay a dividend.
Beta
0.51
EPS
$0.86
Book Value
$30.48
P/E Ratio
283.8x
Price/Sales (TTM)
8.1
Price/Cash Flow (TTM)
153.9x
Operating Margin
0.13%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.